Symbol: |
BCL2L14
|
Description: |
BCL2-like 14 (apoptosis facilitator) [Source:HGNC Symbol;Acc:16657]
|
Location: |
Chr12:12202797-12363947[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:82
Gene |
Compound |
Gen_sig |
Exp_pattern |
BCL2L14 |
Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- |
0.019 |
Down |
BCL2L14 |
NSC 718652 |
0.035 |
Up |
BCL2L14 |
NSC 719715 |
0.019 |
Down |
BCL2L14 |
NSC 720141 |
0.035 |
Down |
BCL2L14 |
1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole |
0.047 |
Down |
BCL2L14 |
NSC 721533 |
0.013 |
Down |
BCL2L14 |
2-fluorphenylhydrazone alpha-lapachone |
0.016 |
Down |
BCL2L14 |
(-)-Dibenzylnortrachelogenin |
0.036 |
Down |
BCL2L14 |
NSC 722876 |
0.035 |
Down |
BCL2L14 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.038 |
Up |
BCL2L14 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.028 |
Up |
BCL2L14 |
N,N' Bis{2-(4-phenylene)benzimidazole}thiourea |
0.032 |
Down |
BCL2L14 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.018 |
Up |
BCL2L14 |
6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.031 |
Up |
BCL2L14 |
BAS100 Monohydrate |
0.038 |
Up |
Expression pattern: Sensitivity / Resistance
Total:6 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:21
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:76
Total:6 Current:1
[First] [Prev]  Next Last 
|